Advanced Medical Solutions Grp PLC Notice of Annual General Meeting and Annual Report (5171E)

TIDMAMS

RNS Number : 5171E

Advanced Medical Solutions Grp PLC

08 May 2017

8 May 2017

Advanced Medical Solutions Group plc

("AMS" or the "Company")

Annual Report and Accounts for the year ended 31 December

2016 and Notice of AGM

Winsford, UK, 8 May: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, is pleased to announce that in accordance with AIM Rules 20 and 26, the Annual Report and Financial Statements for the year ended 31 December 2016 were posted to shareholders today and are available on the Investor Relations section of the Company's website https://www.admedsol.com/investor-relations/.

The notice of meeting convening the Annual General Meeting of the Company, which will be held on 7 June 2017 at 11 am at the offices of Investec Bank plc, 2 Gresham Street, London, EC2V 7QP, was also posted to shareholders today and is available on the Company's website.

- Ends -

For further information, please visit www.admedsol.com or contact:

 
     Advanced Medical Solutions Group            Tel: +44 (0) 
      plc                                         1606 545508 
     Chris Meredith, Chief Executive 
      Officer 
      Mary Tavener, Chief Finance Officer 
 
     Consilium Strategic Communications          Tel: +44 (0) 
                                                 20 3709 5700 
     Mary-Jane Elliott / Jonathan 
      Birt / Matthew Neal / Hendrik 
      Thys 
 
     Investec Bank PLC (NOMAD & Broker)          Tel: +44 (0) 
                                                 20 7597 5970 
     Daniel Adams / Patrick Robb 
 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal(R) , and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand(R) and RESORBA(R) .

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCAPMFTMBMMBFR

(END) Dow Jones Newswires

May 08, 2017 12:10 ET (16:10 GMT)